<DOC>
	<DOCNO>NCT00000429</DOCNO>
	<brief_summary>This study look effect take calcium pill bone health young people juvenile rheumatoid arthritis ( JRA ) . In 2-year study , child age 6-18 JRA take either calcium supplement match placebo ( inactive `` dummy '' pill ) contain calcium . During study , researcher patient know patient take calcium placebo . We believe patient take calcium supplement least 10 percent great increase total body bone mineral density compare patient take placebo . We evaluate patient Children 's Hospital Medical Center every 6 month 2 year . During 2-year period , participant study take one multivitamin contain 400 IU ( international unit ) vitamin D either 1,000 mg calcium carbonate ( Tums tablet ) mouth match placebo day . We check patient 6 18 month 2-year treatment period find people Tums-treated group maintain increase bone formation occur 2-year treatment period .</brief_summary>
	<brief_title>Calcium Supplements Bone Health Juvenile Rheumatoid Arthritis</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled trial 24 month juvenile rheumatoid arthritis ( JRA ) patient take either oral calcium supplement 1,000 mg elemental calcium per day match placebo contain calcium ( Ca ) , plus one multivitamin per day . We hypothesize patient receive calcium supplementation demonstrate least 10 percent great increase total body bone mineral density compare treated placebo . We evaluate patient Children 's Hospital Medical Center ( CHMC ) every 6 month 2 year . We also evaluate patient 6 18 month end intervention period determine persistence demonstrate increase bone mineralization Tums-treated group . The study require analysis human blood urine sample low-dose radiation exposure . We randomize 193 JRA patient equally two treatment group ( active placebo ) . The active treatment group take , single daily dose , two 500 mg tablet elemental Ca CaC03 ( calcium carbonate ) one multivitamin tablet contain 400 IU vitamin D. The placebo treatment group take , single daily dose , two placebo tablet ( match size , appearance , taste ) contain 0 mg elemental Ca one multivitamin tablet contain 400 IU vitamin D. We patient evaluation Clinical Research Center Children 's Hospital Medical Center . Every 6 month 2-year intervention trial , perform interval history , general joint physical exam , anthropometric measurement ( height , weight , BMI ) , pill count , MMEM monitor check , DXA scan total body lumbar spine bone mineral density , dispense study drug . At yearly interval intervention trial , Youth/Adolescent Questionnaire ( YAQ ) diet ( validated 1-year recall ) , 3-day diet diary current intake , blood test mineral calcitropic hormone concentration , 24-hour urine measurement bone turnover marker mineral excretion , physical function assessment ( JAFAR ) , physical activity questionnaire . We obtain blood determine vitamin D receptor ( VDR ) genotype baseline . We perform fast random urine test determine Ca/creatinine ratio ass treatment-induced hypercalciuria month 0 , 3 , 6 , 12 , 18 , 24 . Monthly intervention trial , study coordinator contact participant phone blind fashion increase compliance encourage continue participation trial . We evaluate participant 6 18 moth end intervention trial . At visit , obtain follow : general medication history , general joint physical exam , Tanner Stage , anthropometric measurement , blood mineral calcitropic hormone , 24-hour urine collection measurement bone turnover marker mineral excretion , JAFAR , physical activity questionnaire , total body lumbar spine DXA scan . The YAQ 3-day diet diary complete 42-month visit . Prior every DXA scan , urine pregnancy test menstruating female ensure pregnant . Any patient withdraws blind portion study early complete evaluation outline 24 month visit . Patients withdraw early open phase study complete 42 month evaluation . We exclude study people recently take systemic corticosteroid , people take oral contraceptive , smoker , pregnant woman factor show significantly low bone mineralization . We withdraw subject study demonstrate elevate fasting random urinary calcium/creatinine ratio ( &gt; 0.2 ) , chronic disease addition JRA affect growth bone mineralization , become pregnant . We include patient withdraw study voluntarily `` intention-to-treat '' analysis .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>JRA Diagnosis American College Rheumatology diagnostic criterion Age 618 year Taking calcium supplement calcium contain antacid Taken systemic corticosteroid prior 3 month Use oral contraceptive Smoker Have currently pregnant Have another chronic illness affect growth bone mineralization ( example , Down 's Syndrome , inflammatory bowel disease , steroiddependent asthma ) Fasting random urinary calcium/creatinine ratio &gt; 0.2</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>JRA</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Dietary calcium</keyword>
	<keyword>Diet therapy</keyword>
	<keyword>Bone density</keyword>
	<keyword>Ossification</keyword>
	<keyword>Biomarker</keyword>
	<keyword>Dietary supplement</keyword>
</DOC>